To investigate the effects of warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) in patients with diarrhea-dominant irritable bowel syndrome (D-IBS) by assessing predominant factors, and determining the best factor combinations and their interactions. To identify the optimal quantity of warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) to achieve optimal efficacy.
METHODS: An L9 (3 4 ) orthogonal design was applied to 233 confirmed subjects based on the three most influential factors and the three most frequently used levels. Nine programs were designed. Subjects were assigned to four subgroups according to age and gender; each subject underwent one of the nine programs randomly. We selected Tianshu (ST 25, bilateral) and Qihai (CV 6). The scores of symptoms and the IBS Quality of Life (IBS-QOL) were evaluated after the final treatment.
RESULTS:
After treatment, clinical symptoms of all patients were significantly improved (P = 0.001). Quality of life also improved significantly (P < 0.05). For all the participants, frequency was the dominat-ing factor regarding symptoms (P = 0.01). Duration was the dominating factor for quality of life (P = 0.0001). The best combination for improving symptoms in 30-40-year-old male and female patients was two courses of 10 min each once a day, and for 41-50-year-old male and female patients it was three courses of 10 min (males) or 30 min (females) twice a day. The best combination for quality of life was three courses of 20 min once a day. No interaction was found between frequency and course, or frequency and duration.
CONCLUSION:
Warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) is a promising therapy for D-IBS. To acquire optimal efficacy, the three main factors (duration, frequency and treatment course) of the warming moxibustion should reach a specific quantity and be combined appropriately.
INTRODUCTION
Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by intermittent or persistent abdominal pain or discomfort, altered bowel habits, and abnormal bowel characteristics. [1] [2] [3] Population prevalence rates vary widely. [4] [5] [6] A recent population-based investigation showed that the estimated prevalence of IBS is around 11.2% . 7,8 IBS results in a poor quality of life, 9 high rates of absenteeism, high health care utilization 10 and imposes a substantial economic burden of high direct and indirect productivity costs. 11 Warming moxibustion (WM) is a traditional treatment based on the theories of Traditional Chinese Medicine. It mediates its effects using mainly the heat of burning moxa to stimulate acupoints. We reported that WM is a promising therapy for diarrhea-dominant irritable bowel syndrome (D-IBS) and relies on an appropriate stimulus quantity. [12] [13] [14] Treatment frequency, duration and course are the three most influential factors that contribute to the quantity and effect of moxibustion according to years of clinical observation.
An orthogonal study design is used when a process is affected by several different factors, and is achieved by matching each level of each factor with an equal number of each level of the other factors. There have been no orthogonal designs applied to studies of IBS. [15] [16] [17] [18] Although clinical and animal studies of IBS have been performed with moxibustion, the most effective quantity of WM still remains unknown. [12] [13] [14] 19 This study determined how to determine the most effective quantity for the best effect, which were the predominant factors influencing the effect of moxibustion, which levels are the best and what is the perfect combination of factors.
MATERIALS AND METHODS

Study design
This study was a two-center, randomized, patient-blinded pilot clinical trial to evaluate the efficacy of moxibustion for D-IBS. The trial is registered at Controlled Clinical Trials: ChiCTR-TNRC-10000883. It preliminarily screened predominant factors and the best combination of factors and levels for warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) (WM) for the treatment of D-IBS. We selected the three most commonly used levels of frequency, duration, and courses of treatment in clinical practice and matched the nine different resulting programs. The L9 (3 4 ) orthogonal design was applied to the evaluation of the regularity of moxibustion quantity in patients of different ages and genders. The three main influential factors and their three most frequently used levels were identified (Table 1 ) for a total of nine different programs. Each of the nine treatment programs was repeated six times. The prevalence of IBS was higher for women compared with men and lower for individuals older than 50 years in the general population. 8, 9 In contrast, a previous study reported that in many Eastern countries including China, no female predominance among IBS patients was observed. 20 The prevalence of IBS in women is most common between late teenage to mid-forties, 8, 21 and for males it is between the ages of 20-70 years. 22, 23 Therefore, we set an age of 30-50 years as the inclusion criteria. To maintain homogeneity of the orthogonal design, all patients were divided into four subgroups according to gender and age. The sample size was calculated according to the third version of the statistical package of the Medical Statistics chapter of the Chinese Medical Encyclopedia PEMS 3.1 for Windows. Random method SPSS 13.0 (SPSS Inc., Chicago, IL, USA) was used to generate random numbers, and a sealed envelope was used to assign subjects randomly to one of the nine treatments by assistant physicians according to their visit orders.
Subjects and ethical approval
A total of 233 patients with confirmed D-IBS were recruited from the Shanghai Research Institute of Acupuncture and Meridian, Central Hospital of Jiading District of Shanghai from 2008 to 2011, through newspaper, hospital website, and bulletin boards. All subjects gave written informed consent at the beginning of the trial and were free to withdraw from the study at any time. The study was approved by the local ethics committee.
Inclusion criteria
(a) Meet the Rome Ⅲ diagnostic criteria; [24] [25] [26] 
WM protocol
Tianshu (ST 25, bilateral) and Qihai (CV 6) were selected according to the Nomenclature and Location of Acupuncture Points (GB/T12346-2006). 27 One end of the purifying moxa stick (18 mm × 200 mm; Henan Nanyang Moxa Biological Products Co., Ltd., Henan Province, PR China) was ignited. The distance between the ignited moxa stick and skin was approximately 2 cm. Patients should feel heat that should not burn. Treatments were given according to the programs listed in Table 2 by a physician who had more than three years of moxibustion experience. Each moxibustion session lasted 6 days, and 1-day intervals were set between sessions.
Outcome measures
The primary outcome was a change in symptom score from baseline after WM treatment. Symptom scores were determined according to the criteria of diagnosis and therapeutic effects for clinical diseases and syndromes. 28 It was assessed by a modified gastrointestinal symptom questionnaire. The criteria had three levels: (a) markedly effective: normal defecation with alleviation of other syndromes, R (change rate of symptom score) ≥ 70%; (b) effective: substantially decreased frequency of defecation with improvement in other syndromes, 30% ≤ R ≤ 70% ; and (c) ineffective: no change in frequency of defecation or other syndromes, R < 30%. The secondary outcome was quality of life as assessed by irritable bowel syndrome quality of life (IBS-QOL). 29, 30 
Statistical analysis
Analyses were performed using SPSS 13.0 (SPSS Inc., Chicago, IL, USA). Mean ± standard deviation ( x ± s) were used to describe continuous variables and proportions for categorical data. Differences in means among groups were compared by one-way analysis of variance (ANOVA), the least significant differences test (LSD), and Games-Howell test separately when appropriate. Differences in means within groups were compared using the paired-samples t-test. Wilcoxon's nonparametric test and the two-related-samples test were performed when there was a heterogeneity in variance. Enumeration data were assessed by the χ 2 test or signed rank sum test. A P value < 0.05 was considered statistically significant.
RESULTS
Subjects
Seventeen patients were lost because of the following reasons: business trip (n = 3), pregnancy (n = 1), other medications (n = 6), allergy to WM (itch- iness around the points) (n = 1), and unknown reason (n = 6). The rate of loss was 7% . Finally, there were 216 patients completed the treatment course ( Figure 1 ). The baseline characteristics of patients in the four subgroups were not statistically different (P > 0.05).
Clinical efficacy
Clinical symptoms in different programs showed significant improvement after treatment (P = 0.001) ( Table 3) . There was a significant difference in the total effective rate among the three levels of frequency (χ 2 = 7.187, P = 0.027). Nonparametric tests indicated that level 2 233 Subjects were divided into following four subgroups according to age and gender (once a day) was better than level 1 (once every two days) (P = 0.008). There was no statistical difference between the three levels of duration and treatment courses ( Table 4 ). The IBS-QOL in the different programs improved significantly after treatment (P < 0.05) ( Table 5 ).
Dominating factors
The data of 41-50-year-old male patients is used as an example. For the reason of limited space, the rest of the data is not shown. ANOVA indicated statistical significance among the three levels of the three factors in terms of differences in the scores for clinical symptoms (P = 0.042). Frequency was the dominating factor in improving symptoms of 41-50-year-old male patients, and twice a day was the best frequency ( Table 6 ). The other results are shown in Table 7 . For 30-40year-old male patients, there was no difference among the three factors with regard to improving symptoms or IBS-QOL. For female patients in the 30-40 and 41-50-year-old groups, duration was the dominating factor for IBS-QOL (P = 0.037, P = 0.015). For all the patients in the study, ANOVA results indicated that frequency was the dominating factor among the three levels of the three factors in terms of symptom improvement (P = 0.01). Duration was the dominating factor for IBS-QOL (P = 0.0001).
Interaction of frequency and duration
There was no statistical significance between the frequency and duration in terms of improving symptoms and IBS-QOL in patients of different age and gender. These results indicated that frequency and duration may have separate roles.
Best combination
Comparison of the K value indicated that the best combination for improving symptoms of 41-50-year-old male patients was three treatment courses of 10 min twice a day. To improve the IBS-QOL, the best combination was three treatment courses of 20 min once a day ( Table 8, 9) . The four subgroups results are shown in Table 10 . Table 5 Improvement of life quality score after warming moxibustion treatment ( x ± s ) age, disease, constitution, and season. Many studies have investigated the treatment of IBS with acupunc-ture and moxibustion, [31] [32] [33] [34] [35] but none have reported the most effective quantity of moxibustion.
DISCUSSION
Duration
In a study by Bai, 36 prolonged moxibustion increased the immediate analgesic and postanalgesic effects. However, no direct relationship was found between duration and effect of moxibustion; the pain threshold was gradually reduced when the duration of moxibustion was longer than 20 min. Our results are not fully consistent with those of Bai in terms of the relationship be- Table 7 Predominant factors of symptoms and quality of life in four subgroups Table 8 Comparison of differences in scores for clinical symptoms and quality of life among the three levels of the three factors in 41-50-year-old male patients Notes: the best combination for improving the symptoms of 41-50-year-old male patients was A3B1C3: three treatment courses of 10 min twice a day. To improve the quality of life, the best combination was A2B2C3: three treatment courses of 20 min once a day. A: frequency; B: duration; C: treatment course. tween duration and efficacy. Our study showed that clinical efficacy was not always increased with a prolonged duration of moxibustion. Therefore, the most effective treatment requires a proper stimulus quantity based on patient age, gender, and symptoms. This is also in concordance with theories of ancient physicians about the proper stimulus quantity of moxibustion.
Frequency
This study revealed that frequency was the predominant factor in improving clinical syndromes for all subjects and for 41-50-year-old male patients, twice a day was optimal. This study showed that twice a day was the best frequency with which to influence many indices and indicated that a higher frequency was more effective at improving clinical syndromes. We found no interactions between frequency and duration for the improvement of all syndromes, which indicated that frequency and duration may have separate roles.
Treatment course
This study attempted to determine the influence of treatment course on WM by evaluating three levels of treatment course (6, 12, and 18 days). The effective rate among all three levels improved significantly after treatment, which revealed a relationship between the effect and different levels of WM courses for the improvement of clinical symptoms. Consistent with our assumption, a longer treatment course was more likely to produce a greater effect.
Analysis of the best program
In this study, two courses of 10 min each time once a day was the best combination for the improvement of clinical symptoms in 30-40-year-old male and female patients, while three courses of 10 min (males) or 30 min (females) twice a day was the optimal combination for 41-50-year-old male and female patients. Thus, for younger patients, a lower frequency and shorter treatment course improved symptoms, whereas older patients required a higher frequency and longer treatment course to obtain an optimal effect. This suggests that young patients may have stronger immunity, and thus respond to WM more sensitively. For all subjects, three courses of 20 min once a day was the optimal combination for improved IBS-QOL. No interaction between frequency and duration was found, but the predominant factors for different indi-ces of different ages and genders of patients with D-IBS were identified. These results should help guide clinical practice. However, this study only enrolled Chinese subjects; therefore further studies of different ethnic groups are required. In conclusion, our findings suggest that warming moxibustion Tianshu (ST 25, bilateral) and Qihai (CV 6) improved clinical symptoms and quality of life of IBD patients. To acquire optimal efficacy, the three main factors (duration, frequency and treatment course) of warming moxibustion should reach a specific quantity and be combined appropriately. Table 10 The best combination for symptoms and life quality improvement in four subgroups
